Krystal reports KB407 Phase 1 positive: CFTR expression confirmed in CF lungs

Krystal Biotech/KB407

CORAL-1 Phase 1 highest-dose cohort confirmed lung delivery and wild-type CFTR protein expression in CF patients following inhaled KB407 dosing.